12:00 AM
Dec 05, 2011
 |  BC Week In Review  |  Clinical News  |  Regulatory

Nevanac nepafenac regulatory update

EMA's CHMP issued a positive opinion to extend the indication for Nevanac nepafenac from Novartis' Alcon Laboratories ophthalmic unit...

Read the full 72 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >